Praxbind Dosage & Drug Information

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Side Effects Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Concise Prescribing Info

Contents

Idarucizumab

Indications/Uses

For adult patients treated w/ dabigatran etexilate (Pradaxa) when rapid reversal of its anticoagulant effects is required: For emergency surgery/urgent procedures & in life-threatening or uncontrolled bleeding.

Click to view Praxbind detailed prescribing information

Dosage/Direction for Use

Restricted to hospital use only. Recommended dose: 5 g. 2nd 5 g dose may be considered if recurrence of clinically relevant & potential re-bleeding would be life-threatening w/ prolonged clotting times or patients requiring 2nd emergency surgery/urgent procedure & have prolonged clotting times.

Click to view Praxbind detailed prescribing information

Overdosage

View Praxbind overdosage for action to be taken in the event of an overdose.

Special Precautions

Hypersensitivity. Hereditary fructose intolerance. Underlying disease states predisposing to thromboembolic events. Transient proteinuria. Patients on a controlled Na diet. Pregnancy & lactation. Childn.

Click to view Praxbind detailed prescribing information

Use In Pregnancy & Lactation

Click to view Praxbind detailed prescribing information

Caution For Usage

For caution against possible variation of physical aspect of medicine... Click to view Praxbind detailed prescribing information

Storage

View Praxbind storage conditions for details to ensure optimal shelf-life.

Description

View Praxbind description for details of the chemical structure and excipients (inactive components).

Action

View Praxbind mechanism of action for pharmacodynamics and pharmacokinetics details.

MIMS Class

Antidotes & Detoxifying Agents

ATC Classification

V03AB37 - idarucizumab ; Belongs to the class of antidotes. Used to reverse anticoagulant effects of dabigatran.

Regulatory Classification

Presentation/Packing

Form

Praxbind soln for inj 50 mg/mL

Packing/Price

50 mL x 2 × 1's (P97,757/box)

Praxbind

idarucizumab

Manufacturer:

Boehringer Ingelheim

Distributor:

Metro Drug

Marketer:

Boehringer Ingelheim